{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:33:59Z","timestamp":1791408839917,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mental disorders are among the top causes of disease burden worldwide. Existing evidence regarding the repurposing of antihypertensives for mental disorders treatment is conflicting and cannot establish causation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used Mendelian randomization to assess the effects of angiotensin-converting-enzyme inhibitors (ACEIs), beta blockers (BBs), and calcium channel blockers (CCBs) on risk of bipolar disorder (BD), major depression disorder (MDD), and schizophrenia (SCZ). We used published genetic variants which are in antihypertensive drugs target genes and correspond to systolic blood pressure (SBP) in Europeans and East Asians, and applied them to summary statistics of BD (cases\u2009=\u200941,917; controls\u2009=\u2009371,549 in Europeans), MDD (cases\u2009=\u2009170,756; controls\u2009=\u2009329,443 in Europeans and cases\u2009=\u200915,771; controls\u2009=\u2009178,777 in East Asians), and SCZ (cases\u2009=\u200953,386; controls\u2009=\u200977,258 in Europeans and cases\u2009=\u200922,778; controls\u2009=\u200935,362 in East Asians) from the Psychiatric Genomics Consortium. We used inverse variance weighting with MR-Egger, weighted median, weighted mode, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier. We performed gene-specific analysis and utilized various methods to address potential pleiotropy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After multiple\u00a0testing correction, genetically proxied ACEIs were associated with an increased risk of SCZ in Europeans (odds ratio (OR) per 5\u00a0mmHg lower in SBP 2.10, 95% CI 1.54 to 2.87) and East Asians (OR per 5\u00a0mmHg lower in SBP 2.51, 95% CI 1.38 to 4.58). Genetically proxied BBs were not associated with any mental disorders in both populations. Genetically proxied CCBs showed no benefits on mental disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Antihypertensive drugs have no protection for mental disorders but potential harm. Their long-term use among hypertensive patients with, or with high susceptibility to, psychiatric illness needs careful evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-03218-6","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:02:40Z","timestamp":1704196960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations"],"prefix":"10.1186","volume":"22","author":[{"given":"Bohan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-0057","authenticated-orcid":false,"given":"Jie V.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"3218_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022, 9(2):137\u2013150.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"3","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/wps.20567","volume":"17","author":"TS Stroup","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341\u201356.","journal-title":"World Psychiatry"},{"key":"3218_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/7854_2010_45","volume":"4","author":"JM Meyer","year":"2010","unstructured":"Meyer JM. Antipsychotics and metabolics in the post-CATIE era. Curr Top Behav Neurosci. 2010;4:23\u201342.","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"3218_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jad.2006.03.027","volume":"95","author":"L Johannessen","year":"2006","unstructured":"Johannessen L, Strudsholm U, Foldager L, Munk-J\u00f8rgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95(1):13\u20137.","journal-title":"J Affect Disord"},{"issue":"1","key":"3218_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1752-4458-8-25","volume":"8","author":"IA Kretchy","year":"2014","unstructured":"Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014;8(1):25.","journal-title":"Int J Ment Health Syst"},{"key":"3218_CR6","doi-asserted-by":"crossref","unstructured":"Shahn Z, Spear P, Lu H, Jiang S, Zhang S, Deshmukh N, Xu S, Ng K, Welsch R, Finkelstein S. Systematically exploring repurposing effects of antihypertensives. Pharmacoepidemiol Drug Saf. 2022;31(9):944-52.","DOI":"10.1002\/pds.5491"},{"key":"3218_CR7","doi-asserted-by":"crossref","unstructured":"Carnovale C, Perrotta C, Baldelli S, Cattaneo D, Montrasio C, Barbieri SS, Pompilio G, Vantaggiato C, Clementi E, Pozzi M. Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovasc Res. 2023;119(3):647-67.","DOI":"10.1093\/cvr\/cvac110"},{"key":"3218_CR8","doi-asserted-by":"publisher","first-page":"109262","DOI":"10.1016\/j.neuropharm.2022.109262","volume":"220","author":"PJ Harrison","year":"2022","unstructured":"Harrison PJ, Husain SM, Lee H, Los Angeles AD, Colbourne L, Mould A, Hall NAL, Haerty W, Tunbridge EM. CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology. Neuropharmacology. 2022;220:109262.","journal-title":"Neuropharmacology"},{"issue":"3","key":"3218_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/mp.2017.133","volume":"23","author":"N Dedic","year":"2018","unstructured":"Dedic N, P\u00f6hlmann ML, Richter JS, Mehta D, Czamara D, Metzger MW, Dine J, Bedenk BT, Hartmann J, Wagner KV, et al. Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. Mol Psychiatry. 2018;23(3):533\u201343.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"3218_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/schbul\/sby096","volume":"44","author":"AL Moon","year":"2018","unstructured":"Moon AL, Haan N, Wilkinson LS, Thomas KL, Hall J. CACNA1C: association with psychiatric disorders, behavior, and neurogenesis. Schizophr Bull. 2018;44(5):958\u201365.","journal-title":"Schizophr Bull"},{"key":"3218_CR11","doi-asserted-by":"crossref","unstructured":"Colbourne L, Luciano S, Harrison PJ. Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes. Transl Psychiatry. 2021;11(1):319.","DOI":"10.1038\/s41398-021-01444-1"},{"key":"3218_CR12","doi-asserted-by":"crossref","unstructured":"Chauquet S, Zhu Z, O'Donovan MC, Walters JTR, Wray NR, Shah S. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study. JAMA Psychiatry. 2021;78(6):623-31.","DOI":"10.1001\/jamapsychiatry.2021.0005"},{"issue":"5","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/HYPERTENSIONAHA.120.16590","volume":"77","author":"TG Riemer","year":"2021","unstructured":"Riemer TG, Villagomez Fuentes LE, Algharably EAE, Sch\u00e4fer MS, Mangelsen E, F\u00fcrtig M-A, Bittner N, B\u00e4r A, Zaidi Touis L, Wachtell K, et al. Do \u03b2-blockers cause depression? Hypertension. 2021;77(5):1539\u201348.","journal-title":"Hypertension"},{"issue":"4","key":"3218_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamapsychiatry.2018.3907","volume":"76","author":"JF Hayes","year":"2019","unstructured":"Hayes JF, Lundin A, Wicks S, Lewis G, Wong ICK, Osborn DPJ, Dalman C. Association of hydroxylmethyl glutaryl coenzyme a reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness. JAMA Psychiat. 2019;76(4):382.","journal-title":"JAMA Psychiat"},{"key":"3218_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jad.2022.06.040","volume":"313","author":"J Lintunen","year":"2022","unstructured":"Lintunen J, L\u00e4hteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - a nationwide cohort study. J Affect Disord. 2022;313:43\u20138.","journal-title":"J Affect Disord"},{"issue":"10","key":"3218_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mp.2016.86","volume":"21","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, Harrison PJ. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol Psychiatry. 2016;21(10):1324\u201332.","journal-title":"Mol Psychiatry"},{"key":"3218_CR17","doi-asserted-by":"publisher","first-page":"106024","DOI":"10.1016\/j.phrs.2021.106024","volume":"175","author":"L Zhang","year":"2022","unstructured":"Zhang L, Bao Y, Tao S, Zhao Y, Liu M. The association between cardiovascular drugs and depression\/anxiety in patients with cardiovascular disease: a meta-analysis. Pharmacol Res. 2022;175:106024.","journal-title":"Pharmacol Res"},{"issue":"7","key":"3218_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1017\/S0033291719004094","volume":"51","author":"RJ Shaw","year":"2021","unstructured":"Shaw RJ, Mackay D, Pell JP, Padmanabhan S, Bailey DS, Smith DJ. The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients. Psychol Med. 2021;51(7):1183\u201391.","journal-title":"Psychol Med"},{"key":"3218_CR19","doi-asserted-by":"crossref","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","DOI":"10.1136\/bmj.k601"},{"issue":"4","key":"3218_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","volume":"140","author":"D Gill","year":"2019","unstructured":"Gill D, Georgakis MK, Koskeridis F, Jiang L, Feng Q, Wei WQ, Theodoratou E, Elliott P, Denny JC, Malik R, et al. Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation. 2019;140(4):270\u20139.","journal-title":"Circulation"},{"key":"3218_CR21","doi-asserted-by":"crossref","unstructured":"Zhao JV, Liu F, Schooling CM, Li J, Gu D, Lu X. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study. Diabetologia. 2022;65(4):695-704.","DOI":"10.1007\/s00125-021-05645-7"},{"issue":"4","key":"3218_CR22","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1212\/WNL.0000000000009814","volume":"95","author":"MK Georgakis","year":"2020","unstructured":"Georgakis MK, Gill D, Webb AJS, Evangelou E, Elliott P, Sudlow CLM, Dehghan A, Malik R, Tzoulaki I, Dichgans M. Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes. Neurology. 2020;95(4):e353\u201361.","journal-title":"Neurology"},{"key":"3218_CR23","doi-asserted-by":"crossref","unstructured":"Zhao JV, Schooling CM. Using Mendelian randomization study to assess the renal effects of antihypertensive drugs. BMC Med. 2021;19(1):79.","DOI":"10.1186\/s12916-021-01951-4"},{"issue":"6","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1161\/ATVBAHA.120.315482","volume":"41","author":"MG Levin","year":"2021","unstructured":"Levin MG, Klarin D, Walker VM, Gill D, Lynch J, Hellwege JN, Keaton JM, Lee KM, Assimes TL, Natarajan P, et al. Association between genetic variation in blood pressure and increased lifetime risk of peripheral artery disease. Arterioscler Thromb Vasc Biol. 2021;41(6):2027\u201334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"3218_CR25","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, Ntritsos G, Dimou N, Cabrera CP, Karaman I, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50(10):1412\u201325.","journal-title":"Nat Genet"},{"issue":"3","key":"3218_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","volume":"50","author":"M Kanai","year":"2018","unstructured":"Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, Iwata N, Ikegawa S, Hirata M, Matsuda K, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390\u2013400.","journal-title":"Nat Genet"},{"issue":"4","key":"3218_CR27","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/ije\/dyz155","volume":"49","author":"VM Walker","year":"2020","unstructured":"Walker VM, Kehoe PG, Martin RM, Davies NM. Repurposing antihypertensive drugs for the prevention of Alzheimer\u2019s disease: a Mendelian randomization study. Int J Epidemiol. 2020;49(4):1132\u201340.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3218_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","volume":"53","author":"N Mullins","year":"2021","unstructured":"Mullins N, Forstner AJ, O\u2019Connell KS, Coombes B, Coleman JRI, Qiao Z, Als TD, Bigdeli TB, B\u00f8rte S, Bryois J, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53(6):817\u201329.","journal-title":"Nat Genet"},{"issue":"5","key":"3218_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","volume":"50","author":"NR Wray","year":"2018","unstructured":"Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E, Air TM, Andlauer TMF, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668\u201381.","journal-title":"Nat Genet"},{"issue":"3","key":"3218_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, Coleman JRI, Hagenaars SP, Ward J, Wigmore EM, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22(3):343\u201352.","journal-title":"Nat Neurosci"},{"issue":"7906","key":"3218_CR31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen C-Y, Dennison CA, Hall LS, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502\u20138.","journal-title":"Nature"},{"issue":"11","key":"3218_CR32","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jamapsychiatry.2021.2099","volume":"78","author":"O Giannakopoulou","year":"2021","unstructured":"Giannakopoulou O, Lin K, Meng X, Su M-H, Kuo P-H, Peterson RE, Awasthi S, Moscati A, Coleman JRI, Bass N, et al. The genetic architecture of depression in individuals of East Asian ancestry. JAMA Psychiat. 2021;78(11):1258.","journal-title":"JAMA Psychiat"},{"issue":"12","key":"3218_CR33","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41588-019-0512-x","volume":"51","author":"M Lam","year":"2019","unstructured":"Lam M, Chen C-Y, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019;51(12):1670\u20138.","journal-title":"Nat Genet"},{"key":"3218_CR34","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. ELife. 2018;7:e34408.","DOI":"10.7554\/eLife.34408"},{"issue":"2","key":"3218_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"key":"3218_CR36","doi-asserted-by":"crossref","unstructured":"Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961-74.","DOI":"10.1093\/ije\/dyw220"},{"issue":"4","key":"3218_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"3218_CR38","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3218_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"3218_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12888-019-2040-8","volume":"19","author":"F Liu","year":"2019","unstructured":"Liu F, Gong X, Yao X, Cui L, Yin Z, Li C, Tang Y, Wang F. Variation in the CACNB2 gene is associated with functional connectivity of the Hippocampus in bipolar disorder. BMC Psychiatry. 2019;19(1):62.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"3218_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1192\/bjp.bp.108.057299","volume":"195","author":"M Kivim\u00e4ki","year":"2009","unstructured":"Kivim\u00e4ki M, Batty GD, Singh-Manoux A, Nabi H, Sabia S, Tabak AG, Akbaraly TN, Vahtera J, Marmot MG, Jokela M. Association between common mental disorder and obesity over the adult life course. Br J Psychiatry. 2009;195(2):149\u201355.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"3218_CR42","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.","journal-title":"PLoS Genet"},{"issue":"3","key":"3218_CR43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43(3):922\u20139.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3218_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2018.15","volume":"14","author":"KE Bernstein","year":"2018","unstructured":"Bernstein KE, Khan Z, Giani JF, Cao DY, Bernstein EA, Shen XZ. Angiotensin-converting enzyme in innate and adaptive immunity. Nat Rev Nephrol. 2018;14(5):325\u201336.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3218_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2(3):258\u201370.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"3218_CR46","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/bcp.14572","volume":"87","author":"JV Zhao","year":"2021","unstructured":"Zhao JV, Schooling CM, Leung GM. Using genetics to understand the role of antihypertensive drugs modulating angiotensin-converting enzyme in immune function and inflammation. Br J Clin Pharmacol. 2021;87(4):1839\u201346.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3218_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003455","volume":"18","author":"BI Perry","year":"2021","unstructured":"Perry BI, Burgess S, Jones HJ, Zammit S, Upthegrove R, Mason AM, Day FR, Langenberg C, Wareham NJ, Jones PB, et al. The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study. PLoS Med. 2021;18(3):e1003455.","journal-title":"PLoS Med"},{"issue":"7","key":"3218_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597\u2013608.","journal-title":"Genet Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03218-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:05:50Z","timestamp":1704197150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03218-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03218-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}